Stockscreener 앱 받기
13.96
4.97%
-0.73
시장 영업 전:
13.89
-0.07
-0.50%
Simulations Plus Inc 주식(SLP)의 최신 뉴스
TradingKey - TradingKey
[144] Simulations Plus, Inc. SEC Filing - Stock Titan
Nicholas Company Inc. Buys 78,854 Shares of Simulations Plus, Inc. $SLP - MarketBeat
NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration - Yahoo Finance
Simulations Plus unveils method for QST model integration with microphysiological data in liver risk analysis - Traders Union
Simulations Plus collaborates with NVIDIA during AI drug modeling push - MSN
Simulations Plus, Inc. (SLP): Investor Outlook With A 47% Potential Upside - DirectorsTalk Interviews
SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill
Simulations Plus (SLP) Partners with NVIDIA for Advanced Drug De - GuruFocus
Simulations Plus teams with NVIDIA on drug modeling - Engineering.com
Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - HPCwire
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Benzinga
Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com India
Simulations Plus partners with Nvidia on AI drug development - Investing.com
Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com
Simulations Plus And NVIDIA Collaborate To Scale GPU-Accelerated, AI-Assisted Modeling Workflows - marketscreener.com
Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus
[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan
Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan
Do options traders know something about Simulations Plus stock we don't? - MSN
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Do Options Traders Know Something About Simulations Plus Stock We Don't? - Zacks Investment Research
Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan
Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan
Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan
Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan
AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan
Simulations Plus Q2 2026 earnings preview - MSN
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily
Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN
SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria
Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus
Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks
Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire
SLP SEC FilingsSimulations Plus Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus
What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net
2.05%
2.56%
자본화:
|
볼륨(24시간):